Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Scappaticcio

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 5, 2019
Radioiodine therapy of advanced differentiated thyroid cancer: clinical considerations and multidisciplinary approachLuca Giovanella, Lorenzo Scappaticcio
The International Journal of Biological Markers|October 19, 2020
Significance of "de novo" appearance of thyroglobulin antibodies in patients with differentiated thyroid cancerLorenzo Scappaticcio, Pierpaolo Trimboli, Frederik A Verburg, et al.
Minerva Endocrinology|July 19, 2024
Combining TSH measurement with TIRADS assessment to further improve the detection of thyroid cancersPierpaolo Trimboli, Marco Curti, Amos Colombo, et al.
Cardiovascular Diabetology|January 12, 2021
Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetesDario Giugliano, Miriam Longo, Lorenzo Scappaticcio, et al.
Reviews in Endocrine & Metabolic Disorders|November 26, 2020
Impact of COVID-19 on the thyroid gland: an updateLorenzo Scappaticcio, Fabián Pitoia, Katherine Esposito, et al.
Cardiovascular Diabetology|October 13, 2021
GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling offDario Giugliano, Lorenzo Scappaticcio, Miriam Longo, et al.
Diabetes Research and Clinical Practice|May 29, 2018
Metabolic syndrome and cancer: "The common soil hypothesis"Giuseppe Bellastella, Lorenzo Scappaticcio, Katherine Esposito, et al.
Current Opinion in Pharmacology|July 27, 2021
Mediterranean diet in type 2 diabetes: An updated overview of pharmacological activities of cardiometabolic and reproductive outcomesMiriam Longo, Lorenzo Scappaticcio, Mariangela Caputo, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 26, 2021
Medical treatment of thyrotoxicosisLorenzo Scappaticcio, Giuseppe Bellastella, Maria I Maiorino, et al.
Endocrine|March 24, 2021
The dilemma of <sup>18</sup>F-FDG PET/CT thyroid incidentaloma: what we should expect from FNA. A systematic review and meta-analysisLorenzo Scappaticcio, Arnoldo Piccardo, Giorgio Treglia, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 5, 2019
Radioiodine therapy of advanced differentiated thyroid cancer: clinical considerations and multidisciplinary approachLuca Giovanella, Lorenzo Scappaticcio
The International Journal of Biological Markers|October 19, 2020
Significance of "de novo" appearance of thyroglobulin antibodies in patients with differentiated thyroid cancerLorenzo Scappaticcio, Pierpaolo Trimboli, Frederik A Verburg, et al.
Minerva Endocrinology|July 19, 2024
Combining TSH measurement with TIRADS assessment to further improve the detection of thyroid cancersPierpaolo Trimboli, Marco Curti, Amos Colombo, et al.
Cardiovascular Diabetology|January 12, 2021
Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetesDario Giugliano, Miriam Longo, Lorenzo Scappaticcio, et al.
Reviews in Endocrine & Metabolic Disorders|November 26, 2020
Impact of COVID-19 on the thyroid gland: an updateLorenzo Scappaticcio, Fabián Pitoia, Katherine Esposito, et al.
Cardiovascular Diabetology|October 13, 2021
GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling offDario Giugliano, Lorenzo Scappaticcio, Miriam Longo, et al.
Diabetes Research and Clinical Practice|May 29, 2018
Metabolic syndrome and cancer: "The common soil hypothesis"Giuseppe Bellastella, Lorenzo Scappaticcio, Katherine Esposito, et al.
Current Opinion in Pharmacology|July 27, 2021
Mediterranean diet in type 2 diabetes: An updated overview of pharmacological activities of cardiometabolic and reproductive outcomesMiriam Longo, Lorenzo Scappaticcio, Mariangela Caputo, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 26, 2021
Medical treatment of thyrotoxicosisLorenzo Scappaticcio, Giuseppe Bellastella, Maria I Maiorino, et al.
Endocrine|March 24, 2021
The dilemma of <sup>18</sup>F-FDG PET/CT thyroid incidentaloma: what we should expect from FNA. A systematic review and meta-analysisLorenzo Scappaticcio, Arnoldo Piccardo, Giorgio Treglia, et al.
Pageof 10